BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Stem cell
,
Laser capture microdissection
,
Bleomycin
,
rs6983267
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cytochrome p- 450- 11 beta
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for cytochrome p- 450- 11 beta
Explore Curated Studies Results
Literature
Most Relevant Literature
Pathogenicity of Congenital Adrenal Hyperplasia Induced by the p.P377L Mutation of CYP11B1.
A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase De…
Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease.
Molecular analysis of 12 Chinese patients with 11β-hydroxylase deficiency and in vitro functional st…
CYP11B1 variants influence skeletal maturation via alternative splicing.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CYP2D6 Polymorphism in Patients of General Practice in Austria
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque P…
Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)
Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.
Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ